menu ☰
menu ˟

Abemaciclib stabilizes brain metastases in breast cancer subtype

14 Jun 2019
CHICAGO — Abemaciclib resulted in a clinically meaningful effect on intracranial response rate in patients with brain metastases secondary to hormone receptor-positive, HER2-negative metastatic breast cancer, according to a study presented at the A...

Click here to view the full article which appeared in Hematology Oncology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.